Organometallic compound and organic light-emitting device including the same

US10290818B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10290818-B2
Application numberUS-201615064112-A
CountryUS
Kind codeB2
Filing dateMar 8, 2016
Priority dateOct 14, 2015
Publication dateMay 14, 2019
Grant dateMay 14, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An organometallic compound represented by Formula 1: wherein, in Formula 1, L 11 , M, R 11 to R 17 , m, and n are the same as described in the specification.

First claim

Opening claim text (preview).

What is claimed is: 1. An organometallic compound represented by Formula 1: wherein, in Formula 1, M is selected from a Period 4 transition metal, a Period 5 transition metal, and a Period 6 transition metal, EU, Tb, and Tm; R 11 to R 17 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a cyano group, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and —Si(Q 1 )(Q 2 )(Q 3 ); two adjacent groups selected from R 11 to R 16 are optionally linked to each other to form a saturated or unsaturated ring; R 17 is selected from a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; Q 1 to Q 3 are each independently selected from a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 6 -C 60 aryl group, and a substituted or unsubstituted C 1 -C 60 heteroaryl group; n is selected from 1, 2, and 3; L 11 is selected from a monodentate ligand and a bidentate ligand; and m is selected from 0, 1, 2, 3, and 4. 2. The organometallic compound of claim 1 , wherein M is selected from Ir, Pt, Os, Ru, Rh, Pd, Cu, Ag, Au, Ti, Zr, Hf, Eu, Tb, and Tm. 3. The organometallic compound of claim 1 , wherein M is selected from Ir and Pt. 4. The organometallic compound of claim 1 , wherein M is Ir. 5. The organometallic compound of claim 1 , wherein R 11 to R 17 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and —Si(Q 1 )(Q 2 )(Q 3 ); two adjacent groups selected from of R 11 to R 16 are optionally linked to each other to form a saturated or unsaturated ring; R 17 is selected from a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; and Q 1 to Q 3 are each independently selected from a substituted or unsubstituted C 1 -C 60 alkyl group and a substituted or unsubstituted C 6 -C 60 aryl group. 6. The organometallic compound of claim 1 , wherein R 11 to R 17 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 3 -C 10 cycloalkyl group, and a C 1 -C 10 heterocycloalkyl group, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 3 -C 10 cycloalkyl group, and a C 1 -C 10 heterocycloalkyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, and —I; a phenyl group, a naphthyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; a phenyl group, a naphthyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a naphthyl group, and —Si(Q 11 )(Q 12 )(Q 13 ); and a phenyl group, a naphthyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from a C 1 -C 20 alkyl group, a phenyl group, and a naphthyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, and —I; two adjacent groups selected from R 11 to R 16 are optionally linked to each other to form a saturated or unsaturated ring; R 17 is selected from a phenyl group, a naphthyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group; a phenyl group, a naphthyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, and a naphthyl group; and a phenyl group, a naphthyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrdinyl group, a pyrazinyl group, a pyrimidinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, a dibenzofuranyl group, and a dibenzothiophenyl group, each substituted with at least one selected from a C 1 -C 20 alkyl group, a phenyl group, and a naphthyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, and —I; and Q 11 to Q 13 are each independently selected from a methyl group, an ethyl group, and a phenyl group. 7. The organometallic compound of claim 1 , wherein R 11 to R 17 are each independently selected from hydrogen, deuterium, —F, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, a tert-butyl group, an n-pentyl group, a methoxy group, an ethoxy group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group; a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a sec-butyl group, an iso-butyl group, a tert-butyl group, an n-pentyl group, a m

Assignees

Inventors

Classifications

  • Electricity · mapped topic

  • Electricity · mapped topic

  • of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title

  • containing organic luminescent materials · CPC title

  • Iridium compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10290818B2 cover?
An organometallic compound represented by Formula 1: wherein, in Formula 1, L 11 , M, R 11 to R 17 , m, and n are the same as described in the specification.
Who is the assignee on this patent?
Samsung Electronics Co Ltd, Samsung Sdi Co Ltd
What technology area does this patent fall under?
Primary CPC classification H01L51/0085. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).